Clarius Group, LLC Neoleukin Therapeutics, Inc. Transaction History

Clarius Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$4.65 - $7.75 $376 - $627	-81 Reduced 0.34%	23,514 $113,000
Q3 2021 Oct 18, 2021	BUY	$6.05 - $9.66 $490 - $782	81 Added 0.34%	23,595 $171,000
Q1 2021 Apr 27, 2021	SELL	$11.26 - $15.78 $32,958 - $46,188	-2,927 Reduced 11.07%	23,514 $289,000
Q4 2020 Jan 15, 2021	BUY	$10.17 - $14.56 $29,767 - $42,617	2,927 Added 12.45%	26,441 $373,000
Q3 2020 Oct 09, 2020	BUY	$9.68 - $17.01 $227,615 - $399,973	23,514 New	23,514 $282,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarius Group, LLC with notifications on news.